The Next-Generation Antibody Therapeutics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for next-generation antibody therapeutics has seen a significant growth in the recent past. It was projected to increase from $6.82 billion in 2024 to $7.63 billion in 2025, with a compound annual growth rate (CAGR) of 11.8%.
The Next-Generation Antibody Therapeutics Global Market is projected to expand to a market size of $11.52 billion by 2029. This growth will occur at a Compound Annual Growth Rate (CAGR) of 10.9%.
Download Your Free Sample of the 2025 Next-Generation Antibody Therapeutics Market Report and Uncover Key Trends Now!The key drivers in the next-generation antibody therapeutics market are:
• Development of biosimilars, bispecific antibodies, and nanobodies
• Utilization of patient-centric approaches and immunomodulatory antibodies
• Increase in antibody applications in treating autoimmune diseases and adoption of continuous manufacturing
• Advancements in antibody engineering, digital technologies in antibody design, and drug delivery systems through industry collaborations and real-world evidence-based development.
The next-generation antibody therapeutics market covered in this report is segmented –
1) By Types Of Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Biospecific Antibodies, Antibody-Drug Conjugates, Other Types
2) By Therapeutic Area: Oncology, Autoimmune Diseases, Infectious Diseases, Neurodegenerative Disorders, Other Therapeutic Areas
3) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users
The key trends in the next-generation antibody therapeutics market are:
• Advancements in antibody engineering are expected to shape the future of the market.
• The use of digital technologies in antibody design is an emerging trend.
• Industry collaborations will significantly influence the future of next-generation antibody therapeutics.
• Advancements in drug delivery systems will play an integral role in the future of the market.
The major players in the next-generation antibody therapeutics market are:
• Pfizer Inc
North America was the largest region in the next-generation antibody therapeutics market in 2024